对比增强术中超声在结直肠癌肝转移手术中的Meta分析
该Meta分析纳入11项研究共497例患者,评估对比增强术中超声(CE-IOUS)在结直肠癌肝转移手术中的应用价值。结果显示CE-IOUS识别肝转移灶的敏感度和准确率均高于MDCT、MRI和术中超声(p<0.05),阳性预测值相似;CE-IOUS发现新病灶使51.8%的新病灶患者手术方案改变。作者认为CE-IOUS在分期上优于其他模态,但纳入研究少需谨慎。
要点
- CE-IOUS识别结直肠癌肝转移的敏感度和准确率均高于MDCT、MRI和术中超声。
- CE-IOUS可发现新转移灶,使51.8%的新病灶患者手术方案改变。
- Sonazoid与Sonovue两种造影剂敏感度相似(p>0.05)。
核心结论
- CE-IOUS在结直肠癌肝转移手术分期中优于MDCT、MRI和术中超声,但纳入研究数量少,结论需谨慎对待。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Scopus和Cochrane数据库,遵循PRISMA指南。
- 共纳入11篇文章、497例患者,采用随机效应模型评估比值比、加权均数差和95%置信区间。
诊断标准与关键数值
- CE-IOUS识别结直肠癌肝转移的敏感度和准确率高于MDCT、MRI和IOUS(p<0.05),阳性预测值在各模态间相似。
- CE-IOUS发现新肝转移灶后,128例(占新病灶患者的51.8%)手术方案改变,其中91例(71%)行更广泛肝切除、15例(11.7%)判定不可手术。
- Sonazoid与Sonovue两种造影剂敏感度相似(p>0.05)。
临床应用与阅片要点
- 在结直肠癌肝转移术中,CE-IOUS可用于补充MDCT、MRI和IOUS未发现的病灶,辅助调整手术方案。
- 阅片和报告中应关注CE-IOUS新发现的可切除或不可切除病灶,因其可能改变肝切除范围或手术决策。
局限性
- 纳入研究数量少,作者强调结论需谨慎对待。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to assess the outcomes of contrast-enhanced intraoperative ultrasound (CE-IOUS) for patients with colorectal liver metastases (CRLMs) undergoing surgery.
METHOD: A thorough literature search was performed in PubMed, Scopus, and Cochrane databases, in accordance with the PRISMA guidelines. The Odds Ratio, Weighted Mean Difference, and 95% Confidence Interval were evaluated, by means of Random-Effects model.
RESULTS: Eleven articles met the inclusion criteria and incorporated 497 patients. The present study shows that CE-IOUS is associated with higher sensitivity and accuracy compared with multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and intraoperative ultrasound (IOUS) in identifying CRLMs (p < 0.05). The positive predictive value was similar among the different modalities. Furthermore, new CRLMs were identified by CE-IOUS, thus affecting the surgical plan in 128 patients (51.8% of the patients with new CRLMs). Moreover, 91 patients (71%) underwent a more extensive hepatectomy and 15 patients (11.7%) were considered non-operable. Two alternative contrast agents, Sonazoid and Sonovue, were employed with similar sensitivity (p > 0.05).
CONCLUSION: These outcomes suggest the superiority of the CE-IOUS over MDCT, MRI, and IOUS for the staging of patients with CRLMs undergoing surgery. However, they should be treated with caution given the small number of the included studies.
引用
- Fergadi MP, Magouliotis DE, Vlychou M, et al. A meta-analysis evaluating contrast-enhanced intraoperative ultrasound (CE-IOUS) in the context of surgery for colorectal liver metastases. Abdom Radiol (NY). 2021. PMID: 33969446. doi:10.1007/s00261-021-03096-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。